摘要
由于在当代药物化学杂志中一部分作者的疏忽,2013, 20(1), 144-157一篇由Dulinska-Litewka J, McCubrey JA 和 Laidler P所写的名为“在前列腺癌症中由于雄性激素响应能力的缺失导致的Akt蛋白分子信号的增强”中,出现了一处错误。由UJCM研究委员会分配的一项课题编号很不幸的没有被书写完全。谨慎考虑到这个项目在每次国际会议摘要,发表论文和书籍中的章节的出现,由NCN给予的编号必须是正确的。在这篇文章中被错误给予的编号是“K/PBW/ 000561”,然而它正确的编号应该是“K/PBW/ 000561 - N N401 125638 (1256/B/P01/2010/38)”。我文章的正确的致谢部分如下:
Current Medicinal Chemistry
Title:ADDENDUM: Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer. Dulinska-Litewka J, McCubrey JA, Laidler P. Curr. Med. Chem., 2013, 20(1), 144-157.
Volume: 21 Issue: 32
Author(s): Joanna Dulinska-Litewka
Affiliation:
摘要: Due to an oversight on the part of the authors in Current Medicinal Chemistry, 2013, 20(1), 144-157 of article entitled “Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer” by Dulinska-Litewka J, McCubrey JA and Laidler P, one slip-up was encountered. The project number assigned by the Commission to research UJCM was unfortunately not written completely. To close accounting on this project on each of the presented abstracts from International Meeting - Conferences, publications and chapters in books, the number assigned by the NCN must be given.
The number which was published was K/PBW/ 000561 but it should have been K/PBW/ 000561 - N N401 125638 (1256/B/P01/2010/38). The correct acknowledgement section of my manuscript should be as follows:
Export Options
About this article
Cite this article as:
Dulinska-Litewka Joanna, ADDENDUM: Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer. Dulinska-Litewka J, McCubrey JA, Laidler P. Curr. Med. Chem., 2013, 20(1), 144-157., Current Medicinal Chemistry 2014; 21 (32) . https://dx.doi.org/10.2174/092986732132140930102757
DOI https://dx.doi.org/10.2174/092986732132140930102757 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index to Volume 4
Current Cancer Drug Targets Bortezomib Enhances the Antitumor Effects of Interferon-β Gene Transfer on Melanoma Cells
Anti-Cancer Agents in Medicinal Chemistry The Proteasome in Health and Disease
Current Pharmaceutical Design Editorial
Recent Patents on CNS Drug Discovery (Discontinued) Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Current Gene Therapy Sunflower Trypsin Inhibitor 1 as a Molecular Scaffold for Drug Discovery
Current Pharmaceutical Design Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention
Current Drug Targets Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases
MicroRNA Fusogenic Oncolytic Herpes Simplex Viruses as a Potent and Personalized Cancer Vaccine
Current Pharmaceutical Biotechnology p53 Regulation of Energy Metabolism and Mitochondria Regulation of p53 in Cancer Cells: An Insight into the Role of Manganese Superoxide Dismutase
Current Pharmaceutical Biotechnology An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-Glycoprotein
Current Cancer Drug Targets NMR-based Metabolite Profiling of Pancreatic Cancer
Current Metabolomics Experimental Research on a Novel Iodine-125 Seed Strand Connected Using Magnesium Alloy AZ31
Recent Patents on Anti-Cancer Drug Discovery Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Medicinal Chemistry Anionic Host Defence Peptides from the Plant Kingdom: Their Anticancer Activity and Mechanisms of Action
Protein & Peptide Letters Subject Index To Volume 5
CNS & Neurological Disorders - Drug Targets Characterization of Graphs for Protein Structure Modeling and Recognition of Solubility
Current Bioinformatics TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery